Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide

Homma S., Miyamoto A., Sakamoto S., Kishi K., Motoi N., Yoshimura K.

Source: Eur Respir J 2005; 25: 200-204
Journal Issue: January
Disease area: Interstitial lung diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Homma S., Miyamoto A., Sakamoto S., Kishi K., Motoi N., Yoshimura K.. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J 2005; 25: 200-204

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009



Exhaled nitric oxide is not reduced in infants with cystic fibrosis
Source: Eur Respir J 2006; 27: 350-354
Year: 2006



NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis
Source: Eur Respir J 2012; 39: 546-557
Year: 2012



Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Source: Eur Respir J 2007; 30: 26-30
Year: 2007



Exhaled nitric oxide in respiratory diseases other than asthma
Source: Eur Respir Monogr 2010; 49: 45-55
Year: 2010


Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients
Source: Eur Respir J 2009; 34: 138-144
Year: 2009



Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Source: Eur Respir J 2001; 17: 1267-1270
Year: 2001



Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013

Interstitial pulmonary disorders in indium-processing workers
Source: Eur Respir J 2007; 29: 317-324
Year: 2007



Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005

Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment
Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018
Year: 2019



Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016


Airway acidification and exhaled nitric oxide in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003

Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002



Exhaled nitric oxide after lung transplantation: impact of the native lung
Source: Eur Respir J 2003; 21: 429-432
Year: 2003